U.S. FDA classifies Aurobindo armβs North Carolina plant VAI
Source: The Hindu
Category: Business
Region: General
Published: August 18, 2026 at 02:12
π Summary
With the unit classified as Voluntary Action Indicated (VAI), pending applications for multiple inhalers and other dosage forms filed from this facility can now progress through the U.S. FDAβs review process, the parent company said